Massachusetts House Bill H1313

Massachusetts 2025-2026 Regular Session

• Introduced: 2/27/25
• Refer: 2/27/25

Caption

Relating to patient choice in dispensing of clinician-administered drugs

Impact

If enacted, H1313 will significantly alter the regulations governing how clinician-administered drugs are provided and reimbursed in Massachusetts. It will prohibit health benefit carriers from imposing additional costs or restrictions on patients seeking these medications from their chosen healthcare providers or pharmacies. This change is expected to promote patient autonomy and ensure consistent access to necessary treatments without unexpected financial burdens.

Summary

House Bill H1313, presented by Representative Lindsay N. Sabadosa, aims to enhance patient choice in the dispensing of clinician-administered drugs in Massachusetts. The bill introduces specific definitions for clinician-administered drugs and stipulates that health benefit carriers must not refuse authorization or payment for such drugs administered by participating healthcare providers. The legislation is designed to ensure that patients can access necessary medications regardless of their insurance plan's pharmacy restrictions.

Contention

The bill may face opposition from health benefit carriers concerned about potential increases in operational costs and the impact on their existing pharmacy networks. Critics may argue that the legislation could complicate reimbursement processes and strain the relationship between pharmacies and health plans. Additionally, there could be concerns about inadvertently promoting the use of more expensive clinician-administered drugs over cost-effective alternatives when patients have the freedom to choose.

Additional_points

Overall, H1313 emphasizes the importance of patient choice in healthcare and seeks to remove barriers that prevent patients from receiving essential medications. The bill reflects a growing trend towards more individualized healthcare solutions, balancing patient needs with the operational capabilities of health insurance providers.